Ponatinib for FLT3-ITD Acute Myelogenous Leukemia

Clinical trial NCT02428543 · COMPLETED

Trial details

NCT number: NCT02428543
Sponsor: Versailles Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Lukemia

Start date: 2013-07-01
Primary completion: 2021-10-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.